← Open Payments lookup

NANCY REHFELD: Open Payments

NPI 1093198848 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,718 in 87 payments from 11 companies in 2025. Trend: 2023 $1,158 · 2024 $1,233 · 2025 $1,718

Food & beverage: $1,718
CompanyPaymentsAmount
Alkermes, Inc.11$317
ABBVIE INC.17$283
Otsuka America Pharmaceutical, Inc.18$275
Axsome Therapeutics, Inc.11$248
E.R. Squibb & Sons, L.L.C.5$176
Teva Pharmaceuticals USA, Inc.14$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$107
Janssen Pharmaceuticals, Inc3$62
Tris Pharma Inc2$35
Neurocrine BioSciences, Inc.1$24

Products named: ARISTADA, VRAYLAR, Auvelity, COBENFY, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.